New breast cancer drug identified as a potential therapy for glioblastoma

[News]

The Ivy Brain Tumor Center at the Barrow Neurological Institute, has released the results of its recent Phase 0 clinical trial of the breast cancer drug ribociclib (Kisqali) for the treatment of recurrent glioblastoma.

More... (https://www.news-medical.net/news/20190725/New-breast-cancer-drug-identified-as-a-potential-therapy-for-glioblastoma.aspx)